MAP2K5, mitogen-activated protein kinase kinase 5, 5607
N. diseases: 70; N. variants: 22
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.882 | 0.120 | 15 | 67794500 | intron variant | G/A | snv | 0.29 |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.080 | 15 | 67543173 | 5 prime UTR variant | T/C | snv | 0.15 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.080 | 15 | 67542218 | non coding transcript exon variant | T/C | snv | 0.69 |
|
Digestive System Diseases; Neoplasms | 0.010 | < 0.001 | 1 | 2012 | 2012 | |||||||
|
0.882 | 0.120 | 15 | 67794500 | intron variant | G/A | snv | 0.29 |
|
0.700 | 1.000 | 3 | 2010 | 2013 | ||||||||
|
0.882 | 0.120 | 15 | 67794500 | intron variant | G/A | snv | 0.29 |
|
0.700 | 1.000 | 3 | 2010 | 2013 | ||||||||
|
1.000 | 0.080 | 15 | 67750719 | intron variant | C/G | snv | 0.27 |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.800 | 1.000 | 1 | 2013 | 2013 | |||||||
|
1.000 | 0.040 | 15 | 67724005 | intron variant | G/A;T | snv |
|
0.700 | 1.000 | 1 | 2013 | 2013 | |||||||||
|
1.000 | 0.040 | 15 | 67724005 | intron variant | G/A;T | snv |
|
0.700 | 1.000 | 1 | 2013 | 2013 | |||||||||
|
15 | 67788548 | intron variant | A/T | snv | 0.44 |
|
0.700 | 1.000 | 2 | 2012 | 2014 | ||||||||||
|
15 | 67788548 | intron variant | A/T | snv | 0.44 |
|
0.700 | 1.000 | 2 | 2012 | 2014 | ||||||||||
|
0.851 | 0.120 | 15 | 67807105 | 3 prime UTR variant | C/T | snv | 2.4E-02 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.851 | 0.120 | 15 | 67807105 | 3 prime UTR variant | C/T | snv | 2.4E-02 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.851 | 0.120 | 15 | 67807105 | 3 prime UTR variant | C/T | snv | 2.4E-02 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.851 | 0.120 | 15 | 67807105 | 3 prime UTR variant | C/T | snv | 2.4E-02 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.851 | 0.120 | 15 | 67807105 | 3 prime UTR variant | C/T | snv | 2.4E-02 |
|
Nervous System Diseases; Mental Disorders | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.851 | 0.120 | 15 | 67807105 | 3 prime UTR variant | C/T | snv | 2.4E-02 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
15 | 67667126 | intron variant | T/C;G | snv |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2014 | 2014 | ||||||||||
|
1.000 | 0.080 | 15 | 67744514 | intron variant | A/G | snv | 0.53 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
15 | 67788548 | intron variant | A/T | snv | 0.44 |
|
0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||||
|
1.000 | 0.040 | 15 | 67724005 | intron variant | G/A;T | snv |
|
Pathological Conditions, Signs and Symptoms | 0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.882 | 0.120 | 15 | 67794500 | intron variant | G/A | snv | 0.29 |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.040 | 1.000 | 4 | 2012 | 2016 | |||||||
|
15 | 67784830 | intron variant | T/C | snv | 0.30 |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||||
|
0.882 | 0.120 | 15 | 67794500 | intron variant | G/A | snv | 0.29 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.882 | 0.120 | 15 | 67794500 | intron variant | G/A | snv | 0.29 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
15 | 67771401 | intron variant | G/T | snv | 0.27 |
|
0.700 | 1.000 | 1 | 2017 | 2017 |